By Rose Krebs ( July 27, 2020, 5:46 PM EDT) -- Industrial biotechnology company Amyris Inc. has been hit with a proposed class action in Delaware Chancery Court seeking to halt an upcoming vote on a stock conversion and $200 million stock offering, saying not enough information has been provided for stockholders to make an informed vote....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.